Table 5.

Cox multivariate analysis for retinoblastoma patients

Variables	SE value	Hazard ratio	Risk ratio (95 % CI)	P Value
OS
cTNM stage (III + IV)	1.065	0.085	0.011–0.687	0.021*
TAZ high expression	0.756	0.226	0.051–0.994	0.049*
PFS
cTNM stage (III + IV)	1.097	0.030	0.003–0.254	0.001*
TAZ high expression	0.692	0.144	0.037–0.559	0.005*
LRRFS
cTNM stage (III + IV)	1.062	0.056	0.007–0.452	0.007*
TAZ high expression	0.710	0.195	0.049–0.783	0.021*
DMFS
cTNM stage (III + IV)	1.058	0.084	0.011–0.672	0.019*
+TAZ high expression	0.735	0.228	0.054–0.960	0.044*

*P < 0.05